Is AYLA or XYLD a better dividend investment in 2026?

AYLA currently yields 374.60% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: AYLA offers higher current income.

What is the dividend yield difference between AYLA and XYLD?

AYLA has a forward dividend yield of 374.60% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 363.62 percentage points.

Home › Compare › AYLA vs XYLD

AYLA vs XYLD: Dividend Comparison 2026

AYLA yields 374.60% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AYLA wins by $7105.55M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AYLA

● Live price

374.60%

Share price

$0.53

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7105.58M

Annual income

$4,658,993,972.92

Full AYLA calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — AYLA vs XYLD

📍 AYLA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AYLA	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AYLA + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AYLA pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AYLA

Annual income on $10K today (after 15% tax)

$31,841.17/yr

After 10yr DRIP, annual income (after tax)

$3,960,144,876.98/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, AYLA beats the other by $3,960,142,140.82/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AYLA + XYLD for your $10,000?

AYLA: 50%XYLD: 50%

100% XYLD50/50100% AYLA

Portfolio after 10yr

$3552.80M

Annual income

$2,329,498,595.97/yr

Blended yield

65.57%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AYLA right now

AYLA

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AYLA buys

XYLD buys

No recent congressional trades found for AYLA or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAYLAXYLD

Forward yield	374.60% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$7105.58M ✓	$25.3K
Annual income after 10y	$4,658,993,972.92 ✓	$3,219.02
Total dividends collected	$6876.29M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: AYLA vs XYLD ($10,000, DRIP)

Year	AYLA Portfolio	AYLA Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$48,160	$37,460.20	$10,818	$1,098.39	+$37.3K → AYLA
2	$220,138	$168,606.60	$11,738	$1,222.51	+$208.4K → AYLA
3	$955,821	$720,273.70	$12,774	$1,364.64	+$943.0K → AYLA
4	$3,945,504	$2,922,775.63	$13,944	$1,527.86	+$3.93M → AYLA
5	$15,497,234	$11,275,544.08	$15,270	$1,715.87	+$15.48M → AYLA
6	$57,972,988	$41,390,948.05	$16,775	$1,933.09	+$57.96M → AYLA
7	$206,739,282	$144,708,184.88	$18,490	$2,184.87	+$206.72M → AYLA
8	$703,499,231	$482,288,199.06	$20,450	$2,477.63	+$703.48M → AYLA
9	$2,286,525,626	$1,533,781,448.26	$22,697	$2,819.19	+$2286.50M → AYLA
10	$7,105,576,392	$4,658,993,972.92	$25,280	$3,219.02	+$7105.55M → AYLA

AYLA vs XYLD: Complete Analysis 2026

AYLA — Stock

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.

Full AYLA Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this AYLA vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AYLA vs SCHD AYLA vs JEPI AYLA vs O AYLA vs KO AYLA vs MAIN AYLA vs QYLD AYLA vs JEPQ AYLA vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.